Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Important new indication for Remicade approved by FDA

Nov. 11, 1999

Pfizer discovers new compounds that inhibit MMPs and other related enzymes

Nov. 9, 1999

BioSpecifics announces results of injectable collagenase phase II study

Nov. 8, 1999

Health Canada approves Vioxx for once-daily treatment of osteoarthritis

Nov. 5, 1999

Vertex commences pilot phase II study of VX-745 for rheumatoid arthritis

Nov. 4, 1999

Inhibitors of matrix metalloproteinase enzymes disclosed by HMR

Oct. 29, 1999

Collagenase-selective MMP inhibitors designed by British Biotech for arthritis

Oct. 28, 1999

Centocor submits sBLA to FDA for Remicade as treatment of rheumatoid arthritis

Oct. 21, 1999

Expanded agreement between Vertex and HMR receives Hart-Scott-Rodino clearance

Oct. 21, 1999

Dimethaid granted license for Pennsaid Topical Lotion in the U.K.

Oct. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...